Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/BIOA/vs peers

BIOABioAge Labs, Inc.vs its industry peers

A metric-by-metric comparison of BioAge Labs, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
EmpresaMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
BIOABioAge Labs, Inc.Esta$272M#8—0.7x#130.3x#4—-13.4%#7-1031.5%#5-21.5%#3——-20.1%#6—
SPRYARS Pharmaceuticals, Inc.$299M#1—23.9x#123.5x#2-5.5%#4-2241.8%#16-212.9%#3-1369.1%#15-177.6%#3—-65.1%#13—
BNTCBenitec Biopharma Inc.$296M#2—1.7x#7—-100.0%#7-20.6%#8—-25.8%#5——-46.6%#10—
MPLTMapLight Therapeutics, Inc.$292M#30.1x#10.8x#3——-107.7%#13—-46.3%#8——-58.7%#12—
TTRXTurn Therapeutics Inc.$291M#4—423.9x#14——-80.6%#11—-465.0%#13——119.4%#3—
FULCFulcrum Therapeutics, Inc.$286M#5—0.9x#4—-100.0%#7-670.0%#15—-24.1%#4——-58.4%#11—
LYELLyell Immunopharma, Inc.$279M#6—1.2x#57742.9x#8-41.0%#520.0%#3-748344.4%#9-117.4%#11——-30.6%#7—
CYPHCYPHERPUNK TECHNOLOGIES INC.$277M#74.0x#32.0x#9184.6x#70.0%#3107.4%#2-2737.8%#83.6%#2——519.1%#1—
RCKTROCKET PHARMACEUTICALS, INC.$269M#9—0.7x#2——13.8%#5—-60.5%#10——-31.2%#8—
ARCT$263M#10—1.5x#63.2x#1-46.1%#618.7%#4-93.0%#2-38.3%#6-136.2%#2———
LRMRLarimar Therapeutics, Inc.$261M#11—2.0x#10——-105.5%#12—-130.1%#12-350.3%#4—-35.5%#9—
QTTBQ32 Bio Inc.$260M#122.8x#22.5x#114.8x#3—162.5%#131.5%#128.1%#1——240.3%#2—
BCYC————105.8%#2-29.5%#9-340.4%#4-43.3%#7-372.9%#5———
GLSIGreenwich LifeSciences, Inc.$253M#13—81.0x#13——-11.2%#6—-621.1%#14——102.5%#4—
CAMPCamp4 Therapeutics Corp$245M#14——70.1x#6436.5%#1-55.2%#10-1502.4%#6———-0.3%#5—
ABEO$244M#15—1.9x#841.9x#5—-211.7%#14-1536.9%#7-55.6%#9-121.6%#1———

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

BIOA's peers

SPRYBNTCMPLTTTRXFULCLYELCYPHRCKTARCTLRMRQTTBBCYCGLSICAMPABEO
← BIOA overview